These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6384520)

  • 1. Inhibition of renin by substrate analogue inhibitors containing the olefinic amino acid 5(S)-amino-7-methyl-3(E)-octenoic acid.
    Johnson RL
    J Med Chem; 1984 Oct; 27(10):1351-4. PubMed ID: 6384520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid.
    Johnson RL; Verschoor K
    J Med Chem; 1983 Oct; 26(10):1457-62. PubMed ID: 6352942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitors. Substitution of the leucyl residues of Leu-Leu-Val-Phe-OCH3 with 3-amino-2-hydroxy-5-methylhexanoic acid.
    Johnson RL
    J Med Chem; 1982 May; 25(5):605-10. PubMed ID: 7045370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
    Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
    J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-(alpha-Hydroxyalkanoyl) derivatives of Leu-Val-Phe-OCH3 as inhibitors of renin.
    Johnson RL
    J Med Chem; 1980 Jun; 23(6):666-9. PubMed ID: 6993683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
    Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
    J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
    TenBrink RE; Pals DT; Harris DW; Johnson GA
    J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the specificity of human renin. Studies with peptide inhibitors.
    Poulsen K; Haber E; Burton J
    Biochim Biophys Acta; 1976 Dec; 452(2):533-7. PubMed ID: 1009126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
    Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
    J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model.
    Thaisrivongs S; Pals DT; Lawson JA; Turner SR; Harris DW
    J Med Chem; 1987 Mar; 30(3):536-41. PubMed ID: 3546690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the reaction of renin with nine synthetic peptide substrates.
    Skeggs LT; Lentz KE; Kahn JR; Hochstrasser H
    J Exp Med; 1968 Jul; 128(1):13-34. PubMed ID: 5662012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.
    Maibaum J; Rich DH
    J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of potent, low molecular weight renin inhibitors.
    Sueiras-Diaz J; Jones DM; Szelke M; Deinum J; Svensson L; Westerlund C; Sohtell M
    J Pept Res; 1997 Oct; 50(4):248-61. PubMed ID: 9352463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the inhibition of human renin by an inhibitor containing a hydroxyethylene dipeptide isostere.
    Kati WM; Pals DT; Thaisrivongs S
    Biochemistry; 1987 Dec; 26(24):7621-6. PubMed ID: 3322403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoro ketone containing peptides as inhibitors of human renin.
    Fearon K; Spaltenstein A; Hopkins PB; Gelb MH
    J Med Chem; 1987 Sep; 30(9):1617-22. PubMed ID: 3305947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of potent substrate-analogue inhibitors of canine renin.
    Hui KY; Siragy HM; Haber E
    Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin inhibitors containing statine and 6-aminohexanoic acid. Part III.
    Paruszewski R; Tautt J; Dudkiewicz J
    Pol J Pharmacol; 1993; 45(1):75-82. PubMed ID: 8401762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatically stable renin inhibitors containing statine and 6 aminohexanoic acid. Part IV.
    Paruszewski R; Jaworski P; Tautt J; Dudkiewicz J
    Boll Chim Farm; 1994 May; 133(5):301-8. PubMed ID: 8068237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.